Current role
Biotechnology · Healthcare
Board Member
2023-06-07–present
Anna French, D. Phil.
Board Member
Jasper Therapeutics, Inc. (JSPR)Equibles does not estimate personal net worth.
Get an email with a short summary when Jasper Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get JSPR alertsAbout Anna French, D. Phil.
Anna French, D. Phil. is recorded as Board Member at Jasper Therapeutics, Inc. (JSPR) since June 7, 2023. Jasper Therapeutics, Inc. reported in an 8-K filed June 20, 2024 that Anna French, D. Phil. resigned as Board of Directors, effective June 18, 2024. Jasper Therapeutics, Inc. reported in an 8-K filed June 8, 2023 that Anna French, D. Phil. was appointed Class II director, effective June 7, 2023. Jasper Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jasper Therapeutics, Inc. includes Jeet Mahal (CEO, COO and Board Member), Ronald Martell (CEO and Board Member), William Lis (CEO) and 7 others.
“On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the "Board") of Jasper Therapeutics, Inc. (the "Company") of her intent to resign from the Board effective as of June 18, 2024.”
“To elect two Class II directors to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified.”
Affiliation history
-
Current
2023-06-07–present
-
2023-06-07–2024-06-18
Company network
Leadership on record at Jasper Therapeutics, Inc.
- Jeet Mahal CEO, COO, Board Member
- Ronald Martell CEO, Board Member
- William Lis CEO
- Howard Hoffen Chairman
- Thomas G. Wiggans Chairman, Board Member
- Matthew Ros COO, General Counsel
- Rick Ruiz Chief Accounting Officer
- Christian W. Nolet Board Member
- Judith Shizuru, M.D., Ph.D. Board Member
- Kurt von Emster Board Member